Myriad Genetics MYGN Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's common stock, shares issued (in shares)?
- Myriad Genetics (MYGN) reported common stock, shares issued (in shares) of $94.4M in Q1 2026.
- How has Myriad Genetics's common stock, shares issued (in shares) changed year-over-year?
- Myriad Genetics's common stock, shares issued (in shares) increased by 2.4% year-over-year, from $92.2M to $94.4M.
- What is the long-term trend for Myriad Genetics's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Myriad Genetics's common stock, shares issued (in shares) has grown at a 4.4% compound annual growth rate (CAGR), from $75.4M to $93.5M.